| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |